Hypertension medication therapy is managed collaboratively by clinical pharmacists. Blood pressure is better controlled with this approach. When patients with coronary artery disease are advised to lower their blood pressures, a pharmacistcardiologist collaboration care model may be able to accomplish these more difficult therapy goals. This model of care was used to evaluate patients with high cardiac risk. A retrospective cohort study compared cardiologist-pharmacist care models (n=30) and usual cardiologist care (n=29) to determine whether cardiologist-pharmacist care reduced blood pressure and achieved blood pressure goals (140/90 mmHg) among patients at increased risk of coronary artery disease.). Patients prescribed by cardiologist-pharmacists achieved their target blood pressure at a higher rate than those prescribed by cardiologists alone, 48.3% vs 32.1%, p In the cardiologist-pharmacist care model, systolic blood pressure and pulse pressure, (p=0.0153) were reduced more substantially. Neither systolic nor diastolic pressures were different. There were fewer clinic visits in comparison to usual care, but there were more clinic visits (p<0.0001). Through the evaluation period, antihypertensives were not used significantly more frequently. Using a cardiologist-pharmacist collaboration, this research suggests that group-based hypertension care can improve blood pressure from baseline for patients at high cardiac risk and assist patients in achieving higher blood pressure goals than usual care